On behalf of the Asia Pacific Heart Rhythm Society (APHRS), it is a great honor to host the 18th APHRS Scientific Session at Pacifico Yokohama from November 12th (Wednesday) through November 15th (Saturday), 2025. I also feel a great sense of responsibility. This will be the first APHRS Scientific Session in Japan in eight years since 2017, when it was also held in Yokohama. As in 2017, APHRS2025 will be held jointly with the 71st Japanese Heart Rhythm Society (JHRS) Scientific Session.
The theme of the APHRS2025/JHRS2025 will be “Arrhythmology and Electrocardiology: Entering a New Stage!”
Modern arrhythmia management has made remarkable progress. In addition to comprehensive pharmacotherapy, there are a wide variety of managements including non-pharmacological treatments such as catheter ablation and arrhythmia devices, genetic diagnosis, arrhythmia prediction using AI, and arrhythmia diagnosis using digital devices. The basic research supporting these treatments continues to deepen as well. The theme of this session is to take this advanced arrhythmology and electrocardiology to a new stage.
The APHRS is the first and only society organized in the Asia-Pacific region with the aim of improving the level of medical care and treatment for arrhythmia patients in the region, which is highly diverse in terms of ethnicities, economies, standards or medical care, and science. An important mission of the APHRS is to improve and standardize the level of medical care and treatment for arrhythmia in this region. The APHRS also strives to cooperate with societies representing North America (HRS), Europe (EHRA), Latin America (LAHRS), and other regions.
APHRS2025/JHRS2025 will bring together more than 6,000 participants including cardiologists, electrophysiologists, and other medical professionals, industry leaders who drive innovation, and representatives of companies from not only the Asia-Pacific regions but from around the world. APHRS2025/JHRS2025 will provide an outstanding platform to advance arrhythmia diagnosis and treatment, as well as research, and a forum for networking among experts, so we hope that many of you will participate.
